Psoriatic Arthritis
Latest News
FDA approves oral TYK2 inhibitor deucravacitinib for treating psoriasis
Approval was based on the results of two phase 3 trials of almost 1,700 adults with moderate to severe plaque psoriasis.
From the Journals
Should patients with PsA or ankylosing spondylitis with axial disease be ‘lumped’ or ‘split’?
Patients with isolated axial psoriatic arthritis (PsA) were older at diagnosis, more likely to have psoriatic nail lesions, and less likely to...
From the Journals
Inhaled, systemic steroids linked to changes in brain structure
New research adds to the growing body of evidence suggesting that glucocorticoids have significant effects on the brain, which could explain their...
20th Anniversary
OMERACT continues to set standards on research outcomes, enhancing the patient voice
OMERACT arose from a need to streamline clinical outcome measures in rheumatology, and now with 30 years of...
From the Journals
Autoimmune disease patients’ waxing, waning response to COVID vaccination studied in-depth
Patients with immune-mediated inflammatory diseases have weaker vaccine-induced immunity to COVID but are able to build a humoral immune response...
Latest News
Asian patients with psoriasis have shortest visits, study shows
The reasons for the difference are unclear and in need of further research, according to the study authors.
News from the FDA/CDC
FDA approves adalimumab-bwwd biosimilar (Hadlima) in high-concentration form
The 100-mg/mL version of adalimumab-bwwd (Hadlima) is indicated for the same seven conditions as its 50-mg/mL counterpart.
From the Journals
Biosimilar-to-biosimilar switches deemed safe and effective, systematic review reveals
While switches between biosimilars of the same reference biologic already occur for biosimilars with indications in different specialties, they do...
Latest News
Study suggests psoriasis and PsA are underdiagnosed in underserved groups
“There needs to be improvement in access to quality dermatologic care, as this may help to reduce underdiagnosis of psoriasis and psoriatic...
Guidelines
ACR makes changes to adult, pediatric vaccinations guidance
The pneumococcal, recombinant zoster, and HPV vaccines are among those recommended for patients taking immunosuppressive medications.
News from the FDA/CDC
Ustekinumab becomes second biologic approved for PsA in kids
The approval is based on an extrapolation of data from adult trials in active psoriatic arthritis and adult and pediatric studies in moderate to...